12 Biggest Mid-Day Losers For Friday

• Cellect Biotechnology Ltd. - American Depositary Shares (NASDAQ: APOP) fell 29.5 percent to $4.31. Cellect Biotechnology shares surged Thursday after the company disclosed that it has received a notice of allowance from the US Patent Office protecting its technology in multiple key indications.
• Uranium Resources, Inc. (NASDAQ: URRE) shares dropped 25.2 percent to $2.35 after the company reported the pricing of $9.7 million public offering.
• Skyline Medical Inc (NASDAQ: SKLN) shares declined 19.5 percent to $2.27. Skyline Medical priced its stock and warrant offering for gross proceeds of $3.9 million.
• Marinus Pharmaceuticals Inc (NASDAQ: MRNS) shares fell 15.9 percent to $1.18. Marinus Pharmaceuticals shares have declined 75.99 percent over the past 52 weeks, while the S&P 500 index has climbed 20.11 percent in the same period.
• Inventure Foods Inc (NASDAQ: SNAK) declined 12.2 percent to $6.39. DA Davidson downgraded Inventure Foods from Buy to Neutral and lowered the price target from $10.00 to $8.00.
• Ryerson Holding Corp (NYSE: RYI) dropped 9.2 percent to $12.30. Ryerson projects Q4 loss of $14 million to $11 million including LIFO expense.
• GameStop Corp. (NYSE: GME) dropped 8.3 percent to $22.66. GameStop slashed its comparable sales guidance for the fourth quarter and full year after it reported “disappointing” holiday sales on industry weakness, pricing pressure and lower store traffic.
• Biocept Inc (NASDAQ: BIOC) shares fell 6.6 percent to $1.99. Biocept shares have dropped 55.35 percent over the past 52 weeks, while the S&P 500 index has climbed 20.11 percent in the same period.
• Infosys Ltd ADR (NYSE: INFY) shares declined 5.4 percent to $14.43. Infosys posted Q3 earnings of $0.24 per share on revenue of $2.55 billion.
• MYOS RENS Technology Inc (NASDAQ: MYOS) shares fell 4 percent to $3.60 after dropping 45.01 percent on Thursday.
• Actuant Corporation (NYSE: ATU) dropped 3 percent to $26.05. RBC Capital downgraded Actuant from Outperform to Sector Perform.
• Alamos Gold Inc (US) (NYSE: AGI) slipped around 3 percent to $8.15. Credit Suisse downgraded Alamos Gold from Outperform to Neutral.

© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.